New pill tested to slow Alzheimer's in High-Risk group
NCT ID NCT04693520
Summary
This study tested an oral medication called ALZ-801 in 84 people with early Alzheimer's disease who carry a specific genetic risk factor (the APOE4 gene). The main goal was to see if the drug could affect biological markers of Alzheimer's in the blood and brain over two years, and to check its safety. Participants took the pill twice daily and were monitored for changes in brain scans and blood tests related to the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EARLY ALZHEIMER´S DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Brain Research Center
's-Hertogenbosch, Netherlands
-
Brain Research Center
Amsterdam, Netherlands
-
Brain Research Center
Zwolle, Netherlands
-
Motol University Hospital
Prague, Czechia
-
St. Anne's University Hospital
Brno, Czechia
-
Vestra Clinics
Rychnov nad Kněžnou, Czechia
Conditions
Explore the condition pages connected to this study.